Header cover image

U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies

UPDATED Sep 24, 2023

Companies with a Value score of at least 3, ordered by Value score

230 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
0O1OVetoquinol€78.80-5.0%1.8%€943.0m€101.91PE15.9xE6.4%1.0%
0A5VViatrisUS$9.65-1.5%12.8%US$11.6bUS$12.67PE6.2xE-2.2%5.0%
0QCOPharming Group€1.21-5.0%10.9%€797.6m€1.86PS4.1xE68.0%n/a
0JDMIQVIA HoldingsUS$200.03-4.9%6.5%US$36.4bUS$254.05PE33.2xE16.7%0%
0O14Merck KGaA€158.15-2.2%-0.8%€69.2b€197.69PE22.3xE11.6%1.4%
0QYQGilead SciencesUS$74.73-1.3%19.8%US$93.5bUS$91.02PE17xE7.8%4.0%
0A5JDermapharm Holding€38.40-8.5%1.7%€2.1b€58.63PE16.9xE4.9%2.7%
MRKDMerck KGaA€159.93-0.6%0.2%€69.2b€198.40PE22.5xE11.6%1.4%
0MTDSwedish Orphan Biovitrumkr220.400%8.8%kr74.5bkr285.09PE23.9xE20.5%n/a
INDVLIndiviorUK£18.113.5%27.4%UK£2.5bUK£24.08PS3.2xE42.3%0%
0RLTQiagenUS$36.91-4.1%-13.1%US$9.0bUS$49.34PE18.4xE6.1%n/a
INDVIndiviorUK£17.801.5%30.0%UK£2.5bUK£24.19PS3xE42.3%0%
0Y5EPerrigoUS$32.14-3.7%-19.2%US$4.4bUS$45.51PB0.9xE57.7%3.4%
0R1FBristol-Myers SquibbUS$58.960.5%-16.1%US$123.0bUS$72.54PE15.5xE14.2%3.9%
0IDADynavax TechnologiesUS$13.59-0.4%36.3%US$1.8bUS$24.31PE15.9xE11.6%n/a
0H19Orexokr17.782.1%-8.3%kr616.0mkr25.33PB5xE99.9%n/a
LONNzLonza GroupCHF425.400.05%-3.6%CHF31.7bCHF625.79PE28xE14.7%0.8%
0L35Sarepta TherapeuticsUS$120.331.8%9.9%US$11.2bUS$182.42PS11.1xE64.7%n/a
0KHERevvityUS$110.99-1.4%-11.9%US$13.6bUS$146.56PE54.3xE14.8%0.3%
0J2OHalozyme TherapeuticsUS$39.07-1.0%1.1%US$5.2bUS$51.15PE22.3xE23.2%n/a
0O8GMDxHealth€0.27-2.4%-61.2%€72.2mn/aPS1.4xE61.2%n/a
AZNAstraZenecaUK£111.483.9%12.2%UK£171.2bUK£139.55PE34.2xE18.6%2.1%
0O9BAlmirall€9.07-7.6%2.7%€2.0b€11.53PS2.1xE50.1%2.0%
0R91Mithra Pharmaceuticals€2.04-0.7%-69.7%€146.2m€2.60PS2.1xE73.4%0%
Page 1 of 10